AMENDMENT NUMBER FOUR TO EXCLUSIVE LICENSE AGREEMENT BETWEEN THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AND NEUROGESX, INC.Exclusive License Agreement • August 10th, 2012 • NeurogesX Inc • Pharmaceutical preparations
This Amendment Number four (this “Amendment Number Four”) is made as of April 3, 2012 (“Amendment Date”), between THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200, (the “Regents”), and NEUROGESX, INC., a California corporation with its principal place of business at 2215 Bridgepointe Parkway, Suite 200, San Mateo, California 94404 (“Licensee”) (each individually, a “Party,” and collectively, the “Parties”).
SUBLEASE BETWEEN ORACLE AMERICA, INC. AND NEUROGESX, INC. Second (2nd) FloorSublease • August 10th, 2012 • NeurogesX Inc • Pharmaceutical preparations • California
THIS SUBLEASE (“Sublease”) is entered into as of May 14, 2012 (the “Effective Date”), by and between ORACLE AMERICA, INC., a Delaware corporation (“Sublandlord”) and NEUROGESX, INC., a Delaware corporation (“Subtenant”), with reference to the following facts:
SETTLEMENT, RELEASE AND PATENT ASSIGNMENT AGREEMENTSettlement, Release and Patent Assignment Agreement • August 10th, 2012 • NeurogesX Inc • Pharmaceutical preparations • California
This Settlement, Release and Patent Assignment Agreement (this “Agreement”) is made as of April 3, 2012 (“Effective Date”), by and among NeurogesX, Inc., a California corporation with its principal place of business at 2215 Bridgepointe Parkway, Suite 200, San Mateo, California 94404 (“NeurogesX”), The Regents of the University of California, a California corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200, (the “Regents”), Marco Pappagallo (“Pappagallo”) and Peter Staats (“Staats”) (each individually, a “Party,” and collectively, the “Parties”).
